Business Context and Reporting Period
This Form 8-K Current Report was filed by Blaize Holdings, Inc. on May 5, 2026. The filing discloses the entry into a material definitive agreement for a public offering of common stock and an amendment to existing warrant terms. The Company is an emerging growth company incorporated in Delaware.
Key Financial Metrics and Transaction Details
- Offering Size: 18,918,918 Base Shares of Common Stock at $1.85 per share.
- Over-Allotment Option: Underwriters granted a 30-day option to purchase up to 2,837,837 additional shares.
- Gross Proceeds: Approximately $35.0 million from Base Shares; up to $40.25 million if the option is fully exercised.
- Use of Proceeds: Working capital and general corporate purposes.
- Warrant Amendment: Exercise price for warrants held by Polar Multi-Strategy Master Fund and Polar Long/Short Master Fund reduced from $5.00 to $3.00 per share.
- Lock-Up Period: Executive officers and directors are restricted from disposing of shares for 60 days following the prospectus supplement date.
Material Changes Versus Prior Period
This filing represents a discrete capital event rather than a periodic financial performance report. Consequently, there are no comparative revenue, profit, or cash flow metrics provided in this document. The primary material change is the dilution of existing shareholders due to the issuance of new shares and the modification of warrant exercise prices, which increases the potential dilution from the warrant holders.
Guidance, Outlook, and Risks
- Outlook: The Company intends to utilize net proceeds for working capital, suggesting a focus on liquidity management and operational funding.
- Closing Date: The Offering is expected to close on May 7, 2026.
- Risks and Contingencies: The filing notes that the Underwriting Agreement contains customary representations, warranties, and indemnification obligations. The text does not provide specific quantitative risk factors beyond standard underwriting terms.
- Unusual Items: The reduction of the warrant exercise price from $5.00 to $3.00 is a significant modification of existing debt/equity instruments.
Investor Verification Checklist
- Verify the final closing date and actual gross proceeds received after deducting underwriting discounts and offering expenses.
- Confirm whether the underwriters exercised the 30-day option to purchase the additional 2,837,837 shares.
- Review the full text of the Warrant Amendment (Exhibit 10.2) to understand any other terms modified alongside the exercise price reduction.
- Check the Company's updated capitalization table to assess the immediate dilution impact on existing shareholders.
- Monitor subsequent filings for the actual deployment of the raised capital against the stated "working capital" purpose.